Pharmaceutical company Dr. Reddy's Laboratories (DRL) has said a law firm representing an investor has filed a class action suit in a US court against the company and its executives for alleged violations of US federal securities laws. The lawsuit seeks damages for a purported decline in the company's share price caused by alleged misstatements or omissions.